News & Perspective

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Apr 27, 2012

Apr 27, 2012

Cowpox infection in US lab worker called a first

(CIDRAP News) – A US laboratory worker contracted a painful, slow-healing cowpox virus infection on the job in 2010, marking the first such case reported in the United States, though the virus, a relative of smallpox, is known in Europe and Russia, according to a study published yesterday.

Jun 15, 2011

Jun 15, 2011

Panel calls for refining, paring select-agent list

(CIDRAP News) – A federal advisory committee is recommending that 11 bacterial species and viruses on the current "select agent" list, including anthrax and Ebola virus, be singled out for special safeguards and that another 19 agents be dropped from the list entirely.

Jun 15, 2011

Jun 15, 2011

Measles eradication hits funding, vaccination snags

(CIDRAP News) – A dramatic 78% drop in measles deaths since the start of the decade has global health officials eyeing eradicating the disease, but two major setbacks— resurgence of the disease in Africa and shrinking disease-fighting funds —threaten the efforts, experts said today.

May 23, 2011

May 23, 2011

Smallpox virus destruction talks falter at WHA

(CIDRAP News) – A World Health Assembly (WHA)committee that took up a resolution to destroy the remaining stocks of smallpox virus failed to reach an agreement today, despite a working group's attempts to find an acceptable solution.

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Pages

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get news & practices.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M United Health Foundation Gilead Become an underwriter»